Results 111 to 120 of about 224,676 (168)

Sarilumab in the management of Graves orbitopathy with low clinical activity scores. [PDF]

Sci Rep
Pérez-Moreiras J, Abelenda D, Providência J, Castela G.   +3 more
europepmc   +1 more source

Correction: Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Kim W, Seo MK, Kim YJ, Choi SH, Ku CR, Kim S, Lee EJ, Yoon JS.   +7 more
europepmc   +1 more source

The impact of graves' orbitopathy on anterior segment structures and choroidal parameters. [PDF]

BMC Ophthalmol
Sevimli N, Eryılmaz M, Azarbaz MK, Taydaş G.   +3 more
europepmc   +1 more source

Modulation of gut microbiota in Graves' orbitopathy: Prevotella dominance and atorvastatin's impact. [PDF]

Microbiome
Wang D, Chen Y, Yang J, Zhang Y, Deng X, Liu Y, Chen Y, Yang X, Wang X, Liang C, Xie Q, Hao Y, Yuan H.   +12 more
europepmc   +1 more source

Extracellular vesicles in Graves' disease and Graves' orbitopathy: immunoregulatory mechanisms, biomarkers, and therapeutic potentials. [PDF]

Front Immunol
Chen Y, Yang Y, Yang S, Yuan W, Jiang L, Wei R.   +5 more
europepmc   +1 more source

Therapeutic targets for fibro-inflammation in Graves' orbitopathy. [PDF]

Taiwan J Ophthalmol
Kang YJ, Yoon JS.
europepmc   +1 more source

Pediatric Graves' orbitopathy: TRAb and FT-3 are also prognostic factors in children-A tertiary center study. [PDF]

Thyroid Res
Al-Ghazzawi K, Oeverhaus M, Rama A, Kiewert C, Bechrakis N, Chen Y, Neumann I, Eckstein A.   +7 more
europepmc   +1 more source

Spontaneous Orbital Wall Fracture Secondary to Neglected Graves' Orbitopathy: A Case Report and Review of Current Literature. [PDF]

Case Rep Ophthalmol
Nabie R, Heydarzadeh G, Tahmasbi F.
europepmc   +1 more source

Evaluation of contrast sensitivity function and optic nerve head in patients diagnosed with graves without orbitopathy

Amaç: Graves hastalarında fonksiyonel göz hasarı gelişmeden önce, subklinik evrede gerçekleştirilecek erken tanı ve uygun takip yöntemleriyle geri dönüşü olmayan görme kaybının önlenmesi amaçlanmıştır. Materyal ve Metod: 30 Graves orbitopatisi olan hasta,
Azız, Marıam
core  

Graves' orbitopathy following Alemtuzumab treatment for multiple sclerosis: a systematic review and real-world insights. [PDF]

Thyroid Res
Patera B, Zaffaroni A, Louka S, Gallo D, Piantanida E, Tanda ML.   +5 more
europepmc   +1 more source